Research Topics
Genomes and Genes
| Julie Teruya-FeldsteinSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
MUC-1 mucin protein expression in B-cell lymphomasJulie Teruya-Feldstein
Department of Pathology, Cell Biology and Immunology Programs, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 11:28-32. 2003..For all cases, MUC-1 mucin expression correlated with a previous history of lymphoma (p=0.003)...
The role of chemokines in Hodgkin's diseaseJ Teruya-Feldstein
Department of Pathology, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Leuk Lymphoma 38:363-71. 2000..In addition, we discuss the potential role of chemokines and cytokines in the pathobiology of HD...
Getting the diagnosis right in NHL: role of immunohistochemistry and molecular diagnostic testingJulie Teruya-Feldstein
Immunohistochemistry Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Natl Compr Canc Netw 6:422-7. 2008....
Diffuse large B-cell lymphomas with plasmablastic differentiationJulie Teruya-Feldstein
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Curr Oncol Rep 7:357-63. 2005..In this review, we discuss recently described clinicopathologic insights, case observations, and recently reported molecules involved in terminal B-cell or plasma cell differentiation and their possible roles in disease pathogenesis...
CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleenJulie Teruya-Feldstein
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 17:255-8. 2009..The patient received multiple therapies and ultimately died. This case raises the differential diagnoses of pleomorphic mantle cell lymphoma and other aggressive lymphomas with pleomorphic, anaplastic, and Reed-Sternberg-like cells...
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patientsJ Teruya-Feldstein
Department of Pathology, Memorial Sloan Kettering Cancer Center, NY 10021, USA
Ann Oncol 15:1673-9. 2004....
Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancerJ Teruya-Feldstein
Department of Pathology, Memorial Sloan Kettering Cancer Center, Memorial Hospital, New York, NY 10021, USA
Leuk Lymphoma 43:1619-26. 2002....
The immunohistochemistry laboratory: looking at molecules and preparing for tomorrowJulie Teruya-Feldstein
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Arch Pathol Lab Med 134:1659-65. 2010....
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORRosa Bernardi
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 442:779-85. 2006..Thus, our findings identify PML as a novel suppressor of mTOR and neoangiogenesis...
p63 expression profiles in human normal and tumor tissuesCharles J Di Como
Division of Molecular Pathology, Department of Pathology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 8:494-501. 2002..The p63 gene, located on chromosome 3q27-28, is a member of the p53 gene family. The product encoded by the p63 gene has been reported to be essential for normal development...
Role of the proto-oncogene Pokemon in cellular transformation and ARF repressionTakahiro Maeda
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 433:278-85. 2005..Pokemon's critical role in cellular transformation makes it an attractive target for therapeutic intervention...
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imagingCraig H Moskowitz
Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Br J Haematol 148:890-7. 2010..61. Risk-adapted augmentation of salvage treatment in patients with HL is feasible and improves EFS in poorer-risk patients. Our data suggest that normalisation of FI pre-ASCT predicts outcome, and should be the goal of salvage treatment...
A CK2-dependent mechanism for degradation of the PML tumor suppressorPier Paolo Scaglioni
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 126:269-83. 2006..These data identify a key posttranslational mechanism that controls PML protein levels and provide therapeutic means toward PML restoration through CK2 inhibition...
Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCLCraig H Moskowitz
Lymphoma and Hematology Services of the Division of Hematological Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 106:3383-5. 2005..The cell of origin as determined by IHC does not predict outcome in transplantation-eligible patients with relapsed or primary refractory DLBCL...
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceHui Kuan Lin
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Nature 464:374-9. 2010..Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy...
Expression of p63 in diffuse large B-cell lymphomaCyrus V Hedvat
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Appl Immunohistochem Mol Morphol 13:237-42. 2005..Even though in univariate analysis p63 expression did not correlate with overall survival, the association of p63 with increased proliferative index suggests its involvement in DLBCL tumor progression...
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 103:3684-8. 2004..25). RICE appears to induce very high CR rates in patients with relapsed and refractory DLBCL; however, further studies are necessary to determine whether this treatment regimen will improve outcomes after ASCT...
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphomaCraig H Moskowitz
Departments of Medicine, Radiology, Pathology, and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
J Clin Oncol 28:1896-903. 2010..Outside of a clinical trial, we recommend biopsy confirmation of an abnormal interim FDG-PET scan before changing therapy...
High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphomaDaniel O Persky
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 18:35-40. 2010..We sought to determine if we could identify such markers, and if our comprehensive second-line program could overcome their significance...
Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomasJane Houldsworth
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 103:1862-8. 2004..Nonetheless, these data indicate that DLBCLs are heterogeneous with respect to REL and thus nuclear factor-kappaB (NF-kappaB) activity...
Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphomaTakahiro Itoyama
Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Genes Chromosomes Cancer 35:318-28. 2002..Chromosome arm 1q is gene-rich, and characterization of aberrations described in this study can be expected to lead to the discovery of additional functionally significant genetic changes...
Dissecting eIF4E action in tumorigenesisHans Guido Wendel
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 21:3232-7. 2007..Our results provide insight into how eIF4E contributes to tumorigenesis and pinpoint a level of translational control that may be suitable for therapeutic intervention...
Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRFTakahiro Maeda
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Science 316:860-6. 2007..We propose a new model for lymphoid lineage commitment, in which LRF acts as a master regulator of the cell's determination of B versus T lineage...
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization studyJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mod Pathol 18:1350-6. 2005..Additional studies are needed to determine whether epidermal growth factor receptor gene amplification bears any informative value in predicting response to cetuximab-based therapy...
Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphomaQianxun Xiao
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 12:211-5. 2004..Our results demonstrate that there is differential c-REL protein expression in cHL in comparison with NLPHL and suggest that c-REL may play a role in the pathogenesis of classic Hodgkin lymphoma...
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trialAdam D Cohen
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Br J Haematol 139:224-33. 2007..Risk-adapted SCT with adjuvant thal/dex is feasible and results in low TRM and high haematological and organ response rates in AL patients...
Tumorigenic activity and therapeutic inhibition of Rheb GTPaseKonstantinos J Mavrakis
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Genes Dev 22:2178-88. 2008..Of these, only eIF4E was able to enhance lymphomagenesis in vivo. In summary, the Rheb GTPase is an oncogenic activity upstream of mTORC1 and eIF4E and a direct therapeutic target of farnesyltransferase inhibitors in cancer...
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)Yixuan Gong
Pao Laboratory, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
PLoS ONE 4:e7273. 2009..The IGF receptor type 1 (IGF-1R) pathway is frequently deregulated in human tumors and has become a target of interest for anti-cancer therapy...
Insulin-like growth factor-1 receptor expression in thymic malignanciesNicolas Girard
Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY 10065, USA
J Thorac Oncol 5:1439-46. 2010..As higher levels of IGF-1R protein expression may be associated with relative sensitivity to anti-IGF-1R antibody treatment, we investigated IGF-1R expression in thymic malignancies...
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of diseaseMadhav V Dhodapkar
Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA
Cancer Immun 3:9. 2003..These data suggest that CT antigens may have important biological implications in malignant gammopathies and that CT-7 may be a suitable target for T cell-based and possibly antibody-mediated immunotherapy of myeloma...
Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myelomaHani Hassoun
Division of Hematologic Oncology, Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Br J Haematol 132:155-61. 2006..AD-TD administered with low dose aspirin for deep vein thrombosis prophylaxis was well tolerated and yielded a high response rate with minimal treatment-related morbidity...
Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppressionLi Ma
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 19:1779-86. 2005....
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantationDorothy Pan
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer J 8:371-6. 2002..DISCUSSION: Rituximab is effective and well-tolerated palliative treatment for aggressive non-Hodgkin's lymphomas that relapse after or is refractory to autologous stem cell transplantation...
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphomaJonathan H Schatz
Cancer Biology and Genetics Program, Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA
J Exp Med 208:1799-807. 2011..Hence, targeting the convergence of oncogenic survival signals on translation initiation is an effective alternative to combinations of kinase inhibitors...
Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomasWeiyi Chen
Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Blood 107:2477-85. 2006..Overall, array-CGH identified relatively small genomic regions associated with outcome, which, along with follow-up expression studies, may reveal target genes important in DLBCL clinical behavior...
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphomaElisa Oricchio
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Cell 147:554-64. 2011..Our study attests to the power of combining descriptive tumor genomics with functional screens and reveals EPHA7(TR) as tumor suppressor with immediate therapeutic potential...
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamideOwen A O'Connor
Department of Medicine, Lymphoma, and Developmental Chemotherapy Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 12:2902-11. 2006..To determine whether the combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen can sensitize human lymphoma to cyclophosphamide...
Radiologic features of NUT midline carcinoma in an adolescentDaniel G Rosenbaum
Department of Radiology, New York Presbyterian Hospital Weill Cornell Medical Center, 525 E 68th St, Box 141, New York, NY 10065, USA
Pediatr Radiol 42:249-52. 2012..A newly described but increasingly recognized disease entity, NMC should enter the differential of pediatric midline tumors displaying particularly aggressive characteristics on imaging...
Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphomaSarah T Wilkinson
Department of Pathology, University of Arizona, 1501 N Campbell Avenue, Tucson, AZ 85724 5043, USA
Blood 119:1459-67. 2012..Our observations provide a possible unifying concept that may contribute to the poor outcome reported in all MHC II(-) B-cell tumors...
Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalanPing Zhou
Sloan Kettering Institute, Department of Pathology, New York, NY 10021, USA
Blood 111:549-57. 2008....
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivoEunice S Wang
Laboratory of Developmental Hematopoiesis, Cell Biology Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Blood 104:2893-902. 2004..12, methotrexate) consistently improved tumor responses over those of single-agent therapy. These data support the further clinical development of VEGFR-targeted approaches for the therapy of aggressive DLBCL...
The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphomaAashiyana F Koreishi
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 18:206-11. 2010..0001). Expression of cytotoxic and regulatory T-cells shows prognostic significance in the relapsed/refractory clinical setting of cHL...
Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphomaGouri Nanjangud
Cell Biology Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Blood 99:2554-61. 2002..These studies emphasize the value of SKY analysis for redefinition of chromosomal instability in DLBCL to enhance gene discovery as well as clinical correlation analysis...
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 106:1857-62. 2006..Either antibody may be used for immunohistochemical detection of EGFR in colorectal carcinomas. In addition, manual scoring had an excellent correlation with automated scoring...
SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilizationLydia W S Finley
Department of Pathology, The Paul F Glenn Labs for the Biological Mechanisms of Aging, Harvard Medical School, Boston, MA 02115, USA
Cancer Cell 19:416-28. 2011..Finally, we find that SIRT3 overexpression represses glycolysis and proliferation in breast cancer cells, providing a metabolic mechanism for tumor suppression...
Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphomaCyrus V Hedvat
Laboratory of Cancer Genetics, Cell Biology Program, Department of Pathology and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 33:968-74. 2002..This extensive expression profile of B-cell NHLs and HL tissues discloses the ability of TMAs to rapidly screen a large series of cases and represents the first report of method validation for this technique in the study of lymphoma...
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantJenna D Goldberg
Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Leuk Lymphoma 53:1124-9. 2012..These data demonstrate that allogeneic transplant is a viable option for the treatment of T-NHL and merits prospective evaluation...
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Blood 119:2644-56. 2012....
Synchronous follicular lymphoma, kaposi sarcoma, and castleman's disease in a HIV-negative patient with EBV and HHV-8 coinfectionAashiyana F Koreishi
Department of Pathology and Radiology, Memorial Sloan Kettering Cancer Center, New York, USA
Int J Surg Pathol 19:685-91. 2011....
Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myelomaCyrus V Hedvat
Laboratory of Molecular Aspects of Hematopoiesis, Sloan Kettering Institute, New York, NY, USA
Br J Haematol 122:728-44. 2003..Defining how malignant plasma cell growth is regulated in the bone marrow versus at extramedullary sites will help to delineate the mechanisms underlying the dependence of tumour cell growth on angiogenesis and cell adhesion...
Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomasRodney R Miles
Department of Pathology, University of Utah, Salt Lake City, UT 84112 0565, USA
Hum Pathol 40:1731-7. 2009....
Mad2 overexpression promotes aneuploidy and tumorigenesis in miceRocio Sotillo
Cancer Biology and Genetics Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Cell 11:9-23. 2007..These results demonstrate that transient Mad2 overexpression and chromosome instability can be an important stimulus in the initiation and progression of different cancer subtypes...
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?John Gerecitano
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Br J Haematol 134:391-8. 2006..In fact, the development of an isolated cutaneous vasculitis may portend a better clinical response to bortezomib in some patients...
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphomaEunice S Wang
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021-6306, USA
Cancer 98:1196-205. 2003..In the post-HAART era, intensive chemotherapy such as CODOX-M/IVAC may be appropriate in all adult patients with BL, and especially those with poor prognostic factors, regardless of HIV status...
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosisTakahiro Maeda
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Dev Cell 17:527-40. 2009..Thus, our data define a key transcriptional cascade for effective erythropoiesis, whereby GATA-1 suppresses BIM-mediated apoptosis via LRF...
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphomaTarun Kewalramani
Hematology Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Br J Haematol 134:202-7. 2006..The outcome of ASCT for patients with chemosensitive relapsed or primary refractory PTCL is similar to that for patients with DLBCL...
Ubiquitination regulates PTEN nuclear import and tumor suppressionLloyd C Trotman
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 128:141-56. 2007....
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphomaLorraine E Toner
Laboratory of Experimental Therapeutics for the Lymphoproliferative Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 12:924-32. 2006..These data provide strong rationale for further study of this combination in lymphomas where methotrexate and ara-C are used...
Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemiaRohit Bhargava
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Leuk Lymphoma 45:1043-8. 2004..Cladribine is a potent immunosuppressive agent and should be included with the list of immunosuppressive agents that may be associated with EBV-related B-cell lymphoproliferative disorders...
Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapyKevin N Heller
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York City, New York 10021, USA
J Pediatr Hematol Oncol 26:104-7. 2004....
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancerLi Ma
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Res 67:7106-12. 2007..Importantly, our results indicate that Erk-mediated phosphorylation and inactivation of TSC2 can be critical in development of hamartomatous lesions in TSC and cancer pathogenesis...
ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23)Da Zhang
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 17:172-7. 2009..An add(2)(p23) was also seen not previously reported. Differential diagnoses of neoplasms with plasmablastic differentiation and a comprehensive molecular/cytogenetic literature review of ALK+DLBCL is discussed...
Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markersKlaus J Busam
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 29:400-6. 2005..Despite its reactivity with neutrophils, PNL2 appears to be a valuable supplementary reagent for the diagnosis of melanocytic tumors...
ALK-positive anaplastic large cell lymphoma in a patient with chronic lymphocytic leukemiaTing Liu
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Int J Surg Pathol 18:424-8. 2010..Despite intensive chemotherapy, the patient died. This case represents the rare occurrence of an ALK-positive ALCL developing in a patient with CLL...
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteinsRaymond L Comenzo
Howard 802, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Blood 107:3489-91. 2006..These results justify further study of screening for hereditary variants in patients with apparent AL, and highlight the need for practical techniques for identifying fibrils extracted from tissue...
Cytologic features of plasmablastic lymphomaOscar Lin
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 105:139-44. 2005..Recent studies have reported this neoplasm also in patients without HIV infection and involving sites other than head and neck. This lymphoma has a heterogeneous morphologic presentation but distinct phenotype...
Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 casesJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, U.S.A
Am J Surg Pathol 26:216-24. 2002..The estimated 5-year disease-free survival was 62%, and median disease-free survival was 69 months. The estimated 5-year relapse-free survival was 54%, and the median relapse-free survival was 63 months...
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytesGuenther Koehne
Allogeneic Bone Marrow Transplantation Service, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Nat Biotechnol 21:405-13. 2003..This technique for imaging the migration of ex vivo-transduced antigen-specific T cells in vivo is informative, nontoxic, and potentially applicable to humans...
Sclerosing angiomatoid nodular transformation (SANT) of the spleen: a report of 3 casesAashiyana F Koreishi
Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, USA
Int J Surg Pathol 17:384-9. 2009..However, in 1 patient, a PET scan revealed positive FDG activity, heightening clinical concern for malignancy...
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKBHui Kuan Lin
Department of Pathology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nat Cell Biol 11:420-32. 2009..Finally, we demonstrate that high levels of activation of Akt correlate with the cytosolic accumulation of Skp2 in human cancer specimens. Our results therefore define a novel proto-oncogenic Akt/PKB-dependent signalling pathway...
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mousePaolo Sportoletti
Cancer Biology and Genetics Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Blood 111:3859-62. 2008..Our results conclusively demonstrate that Npm1 acts as a haploinsufficient tumor suppressor in the hematopoietic compartment...
Malignant histiocytoses/disseminated histiocytic sarcoma with hemophagocytic syndrome in a patient with mediastinal germ cell tumorHiroko Shinoda
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Appl Immunohistochem Mol Morphol 17:338-44. 2009..Atypical histiocytes stained positive for CD68, CD163, CD4, CD45 (LCA), and S-100. Cytogenetics studies were negative for i12p. The patient was refractory to therapy and ultimately died 5 months after diagnosis...
In situ localization of follicular lymphoma: description and analysis by laser capture microdissectionPeijie Cong
Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Blood 99:3376-82. 2002..These findings provide insight into the pathophysiology of early FL, and illustrate the utility of immunohistochemistry for early diagnosis...
Role of the chromobox protein CBX7 in lymphomagenesisClare L Scott
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
Proc Natl Acad Sci U S A 104:5389-94. 2007..These data identify CBX7 as a chromobox protein causally linked to cancer development and may help explain the low frequency of INK4a/ARF mutations observed in human follicular lymphoma...
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsMichael T Hemann
Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA
Nature 436:807-11. 2005....
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancerArkaitz Carracedo
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA
J Clin Invest 118:3065-74. 2008....
PML targeting eradicates quiescent leukaemia-initiating cellsKeisuke Ito
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine, Harvard Medical School, New Research Building, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
Nature 453:1072-8. 2008....
Angioimmunoblastic T-cell lymphoma with an evolving Epstein Barr virus-positive diffuse large B-cell lymphoma with unusual clinical and pathologic findingsRodrigo O B Maegawa
Leuk Lymphoma 48:2071-4. 2007
Tumour invasion and metastasis initiated by microRNA-10b in breast cancerLi Ma
Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA
Nature 449:682-8. 2007....
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML networkMin Sup Song
Cancer Genetics Program, Beth Israel Deaconess Cancer Center and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Nature 455:813-7. 2008....
